TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Biofrontera ( (DE:B8FK) ).
Biofrontera AG has announced an extension of the payment deferral agreement with Biofrontera Inc. as negotiations continue regarding their existing license and supply agreement. The discussions may lead to significant changes in Biofrontera AG’s business model and strategic orientation, with a deferral of EUR 1.8 million agreed upon during these talks.
More about Biofrontera
Biofrontera AG is a German company operating in the pharmaceutical industry, focusing on the development and commercialization of dermatological products. The company is known for its innovative treatments and solutions in the dermatology sector.
Average Trading Volume: 1,615
Technical Sentiment Signal: Strong Sell
Current Market Cap: €13.86M
See more insights into B8FK stock on TipRanks’ Stock Analysis page.